Literature DB >> 25695838

TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses.

Tomohisa Okamura1, Shuji Sumitomo2, Kaoru Morita2, Yukiko Iwasaki2, Mariko Inoue2, Shinichiro Nakachi2, Toshihiko Komai2, Hirofumi Shoda2, Jun-Ichi Miyazaki3, Keishi Fujio2, Kazuhiko Yamamoto2.   

Abstract

Autoantibodies induce various autoimmune diseases, including systemic lupus erythematosus (SLE). We previously described that CD4(+)CD25(-)LAG3(+) regulatory T cells (LAG3(+) Treg) are regulated by Egr2, a zinc-finger transcription factor required for the induction of T-cell anergy. We herein demonstrate that LAG3(+) Treg produce high amounts of TGF-β3 in an Egr2- and Fas-dependent manner. LAG3(+) Treg require TGF-β3 to suppress B-cell responses in a murine model of lupus. Moreover, TGF-β3- and LAG3(+) Treg-mediated suppression requires PD-1 expression on B cells. We also show that TGF-β3-expressing human LAG3(+) Treg suppress antibody production and that SLE patients exhibit decreased frequencies of LAG3(+) Treg. These results clarify the mechanism of B-cell regulation and suggest therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25695838      PMCID: PMC4346620          DOI: 10.1038/ncomms7329

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  52 in total

1.  Laminins affect T cell trafficking and allograft fate.

Authors:  Kristi J Warren; Daiki Iwami; Donald G Harris; Jonathan S Bromberg; Bryna E Burrell
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

2.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.

Authors:  Nicola Gagliani; Chiara F Magnani; Samuel Huber; Monica E Gianolini; Mauro Pala; Paula Licona-Limon; Binggege Guo; De'Broski R Herbert; Alessandro Bulfone; Filippo Trentini; Clelia Di Serio; Rosa Bacchetta; Marco Andreani; Leonie Brockmann; Silvia Gregori; Richard A Flavell; Maria-Grazia Roncarolo
Journal:  Nat Med       Date:  2013-04-28       Impact factor: 53.440

3.  Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.

Authors:  Elena Gianchecchi; Domenico Vittorio Delfino; Alessandra Fierabracci
Journal:  Autoimmun Rev       Date:  2013-06-20       Impact factor: 9.754

4.  CD46-induced human Treg enhance B-cell responses.

Authors:  Anja Fuchs; John P Atkinson; Veronique Fremeaux-Bacchi; Claudia Kemper
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

5.  Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+ T cells.

Authors:  Yukiko Iwasaki; Keishi Fujio; Tomohisa Okamura; Atsushi Yanai; Shuji Sumitomo; Hirofumi Shoda; Tomohiko Tamura; Hiroki Yoshida; Patrick Charnay; Kazuhiko Yamamoto
Journal:  Eur J Immunol       Date:  2013-02-26       Impact factor: 5.532

Review 6.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

Authors:  P L Cohen; R A Eisenberg
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

7.  TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes.

Authors:  J Lømo; H K Blomhoff; K Beiske; T Stokke; E B Smeland
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

8.  Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

Authors:  Y Chen; V K Kuchroo; J Inobe; D A Hafler; H L Weiner
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

9.  The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells.

Authors:  Suling Li; Tizong Miao; Meera Sebastian; Punamdip Bhullar; Emma Ghaffari; Mengya Liu; Alistair L J Symonds; Ping Wang
Journal:  Immunity       Date:  2012-09-27       Impact factor: 31.745

Review 10.  Foxp3⁺ T(reg) cells in humoral immunity.

Authors:  James B Wing; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2013-12-09       Impact factor: 4.823

View more
  48 in total

Review 1.  Genetics of autoimmune diseases: perspectives from genome-wide association studies.

Authors:  Yuta Kochi
Journal:  Int Immunol       Date:  2016-02-08       Impact factor: 4.823

2.  Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.

Authors:  Masaki Terabe; Faith C Robertson; Katharine Clark; Emma De Ravin; Anja Bloom; David J Venzon; Shingo Kato; Amer Mirza; Jay A Berzofsky
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

3.  TGFβ Contributes to the Anti-inflammatory Effects of Tauroursodeoxycholic Acid on an Animal Model of Acute Neuroinflammation.

Authors:  Natalia Yanguas-Casás; M Asunción Barreda-Manso; Sandra Pérez-Rial; Manuel Nieto-Sampedro; Lorenzo Romero-Ramírez
Journal:  Mol Neurobiol       Date:  2016-10-15       Impact factor: 5.590

4.  Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.

Authors:  Blair T Stocks; Christopher S Wilson; Andrew F Marshall; Emilee M Hoopes; Daniel J Moore
Journal:  J Immunol       Date:  2019-05-24       Impact factor: 5.422

5.  Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia.

Authors:  Marina Wierz; Sandrine Pierson; Léa Guyonnet; Elodie Viry; Audrey Lequeux; Anaïs Oudin; Simone P Niclou; Markus Ollert; Guy Berchem; Bassam Janji; Coralie Guérin; Jerome Paggetti; Etienne Moussay
Journal:  Blood       Date:  2018-02-13       Impact factor: 22.113

Review 6.  EGR-mediated control of STIM expression and function.

Authors:  Christina K Go; Scott Gross; Robert Hooper; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2018-12-06       Impact factor: 6.817

7.  Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene.

Authors:  Priyanka Shukla; Mohd Nizam Mansoori; Manisha Kakaji; Manoj Shukla; Sushil Kumar Gupta; Divya Singh
Journal:  J Biol Chem       Date:  2017-01-27       Impact factor: 5.157

Review 8.  Tregs in SLE: an Update.

Authors:  Antonio La Cava
Journal:  Curr Rheumatol Rep       Date:  2018-02-21       Impact factor: 4.592

9.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

10.  Therapeutic potential of adenovirus-encoding brain-derived neurotrophic factor for spina bifida aperta by intra-amniotic delivery in a rat model.

Authors:  Wei Ma; Xiaowei Wei; Hui Gu; Dan Liu; Wenting Luo; Dong An; Yuzuo Bai; Zhengwei Yuan
Journal:  Gene Ther       Date:  2020-02-24       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.